Delivery Order SPE2DR25D1205-SPE2DR26F1BS2
Award Date 2/12/26
Potential Completion Date 2/13/26
Potential Value $6.8K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Tolvaptan 15 mg tablets in unit dose packages of 10 units. This is a firm fixed-price delivery order with a ceiling value of $5,100.87 and an ultimate completion date of July 18, 2025. The contract was awarded on a competitive basis without any set-aside designation. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $42,379.77 to AmerisourceBergen Drug Corp for the supply of Tolvaptan 30 mg tablets in unit dose packages of 10s. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 23, 2026, and was awarded on January 22, 2026. This award carries no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, which serves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Tolvaptan 15 mg tablets in unit-dose packaging of 10 units. This competitive award, valued at $44,199.07 on a firm fixed-price basis, is scheduled for completion by November 17, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $21,076.03 to AmerisourceBergen Drug Corp for the supply of Tolvaptan 30 mg tablets in unit-dose packaging of 10 units. This firm fixed-price delivery order, awarded on December 15, 2025, with an ultimate completion date of December 16, 2025, represents a competitive procurement with no set-aside designation. The pharmaceutical product will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $70,470.28 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Tolvaptan 15 mg tablets in unit dose packages of 10. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award selection. Performance will be executed from the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date of December 16, 2025. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Tolvaptan 15 mg tablets in unit-dose packaging (10 count). This is a firm fixed-price delivery order with a ceiling value of $12,218.27 and an ultimate completion date of October 31, 2025. The contract represents a non-set-aside, competitively awarded procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- On January 22, 2026, the Defense Logistics Agency awarded a delivery order valued at $58,683.97 to AmerSourceBergen Drug Corp for the supply of Tolvaptan 15 mg tablets in unit dose packages of 10. This firm fixed-price, competitively awarded contract has an ultimate completion date of January 23, 2026 and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract is a child order under AmerSourceBergen's parent company, Cencora, Inc., which holds a substantial...
- The Defense Logistics Agency (DLA) awarded a $2,880 delivery order to AmerisourceBergen Drug Corp for Tolvaptan 30 mg tablets in unit dose packaging on January 16, 2026, with an ultimate completion date of January 20, 2026. This non-set-aside contract was competitively awarded on a firm fixed-price basis to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as...
- The Defense Logistics Agency awarded a delivery order valued at $15,233.64 to AmerisourceBergen Drug Corp for the supply of Tolvaptan 15 mg tablets in unit dose packaging of 10s. This non-set-aside contract was competitively awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract utilizes firm fixed price pricing and represents a child delivery order issued under a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Tolvaptan 30 mg tablets in unit dose packaging of 10s. This contract is a non-set-aside, competitively awarded delivery order with firm fixed pricing, valued at $48,454.20, with a completion date of September 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F1BS2Delivery Order
The Defense Logistics Agency issued a $6,803.70 delivery order to Amerisourcebergen Drug Corp on February 12, 2026, for Tolvaptan 30 mg tablet unit dose packs. The order has an ultimate completion date of February 13, 2026. Place of performance is Conshohocken, PA. Pricing is firm fixed price. The order was not set aside and was competitively awarded. The source does not identify the parent IDV by name; however, Amerisourcebergen Drug Corp holds a significant DLA Troop Support Medical indefinite delivery contract valued at $999,999,999 through December 2026 that serves as the primary vehicle for pharmaceutical supply across military healthcare programs.
Generated 5/13/26, 10:05 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 2/11/26 |